Celexa and Moxifloxacin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Celexa (citalopram hydrobromide) and Moxifloxacin (moxifloxacin). Common drug interactions include ingrown hair among females and back pain among males.

The phase IV clinical study analyzes what interactions people have when they take Celexa and Moxifloxacin. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Celexa?

Celexa has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 56,390 Celexa users. Check the latest studies of Celexa.

What is Moxifloxacin?

Moxifloxacin has active ingredients of moxifloxacin. eHealthMe is studying from 12,980 Moxifloxacin users. Check the latest studies of Moxifloxacin.



On Jul, 30, 2026

23 people who take Celexa and Moxifloxacin together, and have interactions are studied.

Celexa and Moxifloxacin drug interactions.

What are the common drug interactions of Celexa and Moxifloxacin, by gender? *:

female:

  1. Ingrown hair
  2. Injury
  3. Intervertebral disc degeneration (spinal disc degeneration)
  4. Joint injury
  5. Keratoconjunctivitis sicca (inflammation of the conjunctiva and cornea of the eye with decreased tears)
  6. Lacrimation increased
  7. Lung consolidation (a condition whereby the lung tissues solidify because of the accumulation of solid and liquid material in the air spaces)
  8. Lung disorder (lung disease)
  9. Lymphoedema (localized fluid retention and tissue swelling)
  10. Malignant pleural effusion (a condition in which cancer causes an abnormal amount of fluid to collect between the thin layers of tissue lining of lung)

male:

  1. Back pain
  2. Pain in extremity
  3. Hepatomegaly (abnormal enlargement of the liver)
  4. Injury
  5. Interstitial lung disease
  6. Intervertebral disc protrusion (spinal disc protrusion)
  7. Lumbar radiculopathy (radicular pain in the low back and legs)
  8. Nephrolithiasis (calculi in the kidneys)
  9. Nerve root injury lumbar (nerve root injury at the lumber vertebra)
  10. Neuropathy peripheral (surface nerve damage)

What are the common drug interactions of Celexa and Moxifloxacin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anaemia (lack of blood)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Arthropathy
  4. Back pain
  5. Bone disorder
  6. Cardiomegaly (increased size of heart than normal)
  7. Compression fracture (fracture due to pressure caused by injury)
  8. Disability
  9. Hepatic steatosis (fatty liver disease)
  10. Hepatomegaly (abnormal enlargement of the liver)

50-59:

  1. Osteomyelitis (infection of bone)
  2. Pericardial effusion (fluid around the heart)
  3. Platelet count increased
  4. Red blood cell count decreased
  5. Scoliosis (a medical condition in which a person's spine is curved from side to side)
  6. Sputum purulent
  7. Tremor (trembling or shaking movements in one or more parts of your body)
  8. Vertebral foraminal stenosis (narrowing of the intervertebral foramen)
  9. Arthralgia (joint pain)
  10. Bone pain

60+:

  1. Abdominal distension
  2. Abdominal pain
  3. Cataract (clouding of the lens inside the eye)
  4. Constipation
  5. Diarrhoea
  6. Fatigue (feeling of tiredness)
  7. Secondary immunodeficiency (lack of immunity due to some disease)
  8. Wheezing (a high-pitched whistling sound made while you breath)
  9. Depression suicidal (suicide depressive disorder)
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

What are the existing conditions these people have? *

  1. Breast Cancer: 6 people, 26.09%
  2. Metastases To Bone (cancer spreads to bone): 5 people, 21.74%
  3. Bone Cancer Metastatic: 5 people, 21.74%
  4. Osteomyelitis (infection of bone): 4 people, 17.39%
  5. Renal Disorder (kidney disease): 3 people, 13.04%
  6. Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 3 people, 13.04%
  7. Diabetes: 3 people, 13.04%
  8. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 8.70%
  9. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 8.70%
  10. Asthma: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Celexa and Moxifloxacin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Celexa and Moxifloxacin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Celexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Moxifloxacin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Celexa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Moxifloxacin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on citalopram hydrobromide and moxifloxacin (the active ingredients of Celexa and Moxifloxacin, respectively), and Celexa and Moxifloxacin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: